跳至主要内容
临床试验/CTRI/2022/10/046411
CTRI/2022/10/046411进行中(未招募)4 期

Efficacy and safety of Bupropion in Glycemic control and self-care Adherence in type 2 diabetes with milddepression: A randomised open-labelled crossover controlled trial

ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age of 30 – 70 years
  • 2.Diagnosis of type 2 Diabetes Mellitus as per IDF criteria
  • 3.Duration of T2 DM for 5 years or more
  • 4.HbA1c between 6.5% and 12%
  • 5.Having a score of 5-9 (mild) on Patient Health Questionnaire-9

排除标准

  • 1.Type 1 Diabetes Mellitus
  • 2.Patient who had any significant neurological disorders, or with any significant medical or surgical condition
  • 3.History of traumatic brain injury
  • 4.Patient having any co-morbid psychiatric disorder other than mild depression, or history of any psychiatric illness
  • 5.Treatment with antipsychotic or antidepressant medications, benzodiazepines, dopaminergic medications, monoamine oxidase inhibitors, or amantadine within the last 4 weeks before study participation
  • 6.Pregnant and lactating women
  • 7.History of allergy/intolerance to Bupropion

研究者

发起方
ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR

相似试验